Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease.

@article{Linazasoro2004ConversionFD,
  title={Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease.},
  author={Gurutz J Linazasoro},
  journal={Journal of neurology},
  year={2004},
  volume={251 3},
  pages={335-9}
}
BACKGROUND Pramipexole is a nonergoline dopamine agonist with D2 and preferential D3 dopamine receptor activity. This selective activity may result in clinically different effects. Small clinical trials indicate that overnight switching from one agonist to another can be performed safely. Objective To determine safety and efficacy of overnight switching from dopamine agonists to pramipexole in patients with advanced Parkinson's disease (PD). OBJECTIVE To determine safety and efficacy of… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Similar Papers

Loading similar papers…